Rare Diseases
Commentary
DTC genetic health risk tests: Beware
The Food and Drug Administration recently authorized 23andMe to provide consumers with results of germline DNA sequence variants associated with...
From the Journals
New diagnostic tool identifies severe ADAMTS13 deficiency
A new diagnostic tool – the PLASMIC score – predicts severe ADAMTS13 deficiency, effectively distinguishing thrombotic thrombocytopenic purpura...
Article
Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone
Article
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
Article
Largest-Ever Study of Pemphigus and Pemphigoid Launched
Article
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
Article
Film Festival Devoted to Rare Diseases Scheduled for October
Article
Save the Date for the 2017 NORD Summit
Article
NORD and Neurology Reviews Publish Special Report
Article
NORD Announces Recipients of 2017 Rare Impact Awards
News
Safety of N9-GP for hemophilia B needs further study, FDA committee agrees
The investigational factor IX product nonacog beta pegol for the treatment of hemophilia B has a possible safety issue that had the Food and Drug...